Alberta Investment Management Corp (AIMCo)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,800
Closed -$1.26M 1378
2022
Q1
$1.26M Hold
3,800
0.01% 903
2021
Q4
$1.36M Hold
3,800
0.01% 678
2021
Q3
$1.24M Hold
3,800
0.01% 738
2021
Q2
$1.19M Buy
+3,800
New +$1.17M 0.01% 751
2021
Q1
Sell
-44,367
Closed -$14.4M 948
2020
Q4
$14.4M Sell
44,367
-6,513
-13% -$1.8M 0.13% 183
2020
Q3
$14.1M Hold
50,880
0.15% 159
2020
Q2
$12.3M Buy
50,880
+8,217
+19% +$1.65M 0.15% 167
2020
Q1
$6.19M Buy
42,663
+7,856
+23% +$1.3M 0.11% 224
2019
Q4
$5.94M Buy
34,807
+10,007
+40% +$1.86M 0.05% 315
2019
Q3
$4.41M Hold
24,800
0.04% 364
2019
Q2
$6.46M Buy
24,800
+11,500
+86% +$3.05M 0.06% 291
2019
Q1
$3.8M Buy
13,300
+2,300
+21% +$764K 0.04% 379
2018
Q4
$3.58M Sell
11,000
-1,200
-10% -$417K 0.04% 335
2018
Q3
$5.49M Buy
+12,200
New +$4.81M 0.05% 327

Other funds holding ABMD

Alberta Investment Management Corp (AIMCo)'s ABMD Position: Q2 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 3,800 shares — an estimated $1.26M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ABMD in Q3 2018 and held it in 14 quarters. The position peaked at $14.4M in Q4 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 3,800 Abiomed Inc shares in Q2 2022, an estimated $1.26M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Abiomed Inc in Q3 2018 and held it in 14 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Abiomed Inc position peaked at $14.4M in Q4 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2022, filed 15 Aug 2022.